SCHEMBL1880221

SCHEMBL1880221

CC(N)CCCCCC(=O)O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRP O00591 2/20 0.67
GABRD O14764 2/20 0.67
GABRA1 P14867 2/20 0.67
GABRB1 P18505 2/20 0.67
GABRG2 P18507 2/20 0.67
GABRB3 P28472 2/20 0.67
GABRA5 P31644 2/20 0.67
GABRA3 P34903 2/20 0.67
GABRA2 P47869 2/20 0.67
GABRB2 P47870 2/20 0.67
GABRA4 P48169 2/20 0.67
GABRE P78334 2/20 0.67
GABRA6 Q16445 2/20 0.67
GABRG1 Q8N1C3 2/20 0.67
GABRG3 Q99928 2/20 0.67
GABRQ Q9UN88 2/20 0.67
ALDH1A1 P00352 3/20 0.62
ENPEP Q07075 1/20 0.55
TSHR P16473 5/20 0.55
LMNA P02545 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL538579 1.00 GABRP (0.67) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL1881592 1.00 GABRP (0.67) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL31158246 1.00 GABRP (0.67) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL1876354 1.00 GABRP (0.67) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL1879457 1.00 GABRP (0.67) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL1882607 1.00 GABRP (0.67) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL244824 1.00 GABRP (0.67) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL1885384 1.00 GABRP (0.67) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL1875146 1.00 GABRP (0.67) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL1882596 1.00 GABRP (0.67) GABRPGABRDGABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12404419-B2 Imide addition-fragmentation agents 3M INNOVATIVE PROPERTIES COMPANY (US) 2025-09-02 US disclosed
US-12398301-B2 Adhesives comprising cyclic imide addition-fragmentation and adhesion agents 3M INNOVATIVE PROPERTIES COMPANY (US) 2025-08-26 US disclosed
US-12360106-B2 Photochromic xanthene fluorophores and their utility in live-cell imaging beyond the diffraction limit HOWARD HUGHES MEDICAL INSTITUTE (US) 2025-07-15 US disclosed
US-12329833-B2 Dental compositions SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2025-06-17 US disclosed
CN-120059454-A Antibacterial, antistatic, halogen-free and flame-retardant reinforced polyamide composition and preparation method thereof 中国商用飞机有限责任公司 2025-05-30 CN disclosed
CN-119490745-A Flame retardant polyamide composition and method for preparing same 中国商用飞机有限责任公司 2025-02-21 CN disclosed
US-20250049644-A1 Dental Compositions SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2025-02-13 US disclosed
CN-115443301-B Masterbatch, resin composition, molded article, and method for producing same DIC株式会社 2025-02-11 CN disclosed
US-20250012787-A1 Photochromic xanthene fluorophores and their utility in live-cell imaging beyond the diffraction limit HOWARD HUGHES MEDICAL INSTITUTE (US) 2025-01-09 US disclosed
US-20250011633-A1 Adhesives Comprising Cyclic Imide Addition-Fragmentation And Adhesion Agents 3M INNOVATIVE PROPERTIES COMPANY 2025-01-09 US disclosed
US-20020183265-A1 Manufacture and use of an antibiotic/antibiotics preparation HERAUES KULZER GMBH & CO.KG (DE) 2002-12-05 US disclosed
US-20020182251-A1 Antibiotic(s) preparation with retarding active ingredient release HERAUES KULZER GMBH & CO.KG (DE) 2002-12-05 US disclosed
CN-1376469-A Slow release antibiotics preparation of bioactive substance HELLICH GUESA KG (DE) 2002-10-30 CN disclosed
US-6441131-B1 SYNTHETIC PEPTIDES WITH TERMINAL ANILINE, AMINOCOUMARINE, OR AMINONAPHTHALENE DERIVATIVE RESIDUE AS SUBSTRATE FOR HUMAN PEPSIN OR PEPSINOGEN; DIAGNOSIS OF GASTROINTESTINAL DISORDERS SUCH AS GASTRIC CANCER OR GASTRIC ULCERS ONO PHARMACEUTICAL CO., LTD. (JP) 2002-08-27 US disclosed
EP-1046650-A1 PEPTIDES, METHOD FOR ASSAYING HUMAN PEPSINOGEN II or HUMAN PEPSIN II, AND ASSAYING KIT ONO PHARMACEUTICAL CO., LTD. (JP) 2000-10-25 EP disclosed
EP-0593769-B1 THERMOPLASTIC ELASTOMER COMPOSITION NIPPON ZEON CO (JP) 1997-10-22 EP disclosed
US-5541258-A CROSSLINKED ACRYLATE COPOLYMER RUBBERS WITH CARBOXY GROUPS AND EPOXY GROUPS NIPPON ZEON CO., LTD. (JP) 1996-07-30 US disclosed
EP-0594854-B1 THERMOPLASTIC ELASTOMER COMPOSITION NIPPON ZEON CO (JP) 1996-05-29 EP disclosed
EP-0594854-A1 THERMOPLASTIC ELASTOMER COMPOSITION NIPPON ZEON CO., LTD. (JP) 1994-05-04 EP disclosed
EP-0593769-A1 THERMOPLASTIC ELASTOMER COMPOSITION NIPPON ZEON CO., LTD. (JP) 1994-04-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250049644-A1 Dental Compositions ARCN1, EEF1D, EBP GABRP 590/4885GABRD 845/4885GABRA1 1277/4885
US-12360106-B2 Photochromic xanthene fluorophores and their utility in live-cell imaging beyond the diffraction limit XPA, KIF20A, KIF20B GABRP 4866/4885GABRD 4856/4885GABRA1 4850/4885
US-12329833-B2 Dental compositions ARCN1, EEF1D, EBP GABRP 590/4885GABRD 845/4885GABRA1 1277/4885
US-20250012787-A1 Photochromic xanthene fluorophores and their utility in live-cell imaging beyond the diffraction limit XPA, KIF20A, KIF20B GABRP 4861/4885GABRD 4848/4885GABRA1 4842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.